GSK Plc (GSK)
51.79
-0.62
(-1.18%)
USD |
NYSE |
Aug 24, 16:00
51.79
0.00 (0.00%)
After-Hours: 20:00
GSK Debt to Equity Ratio : 1.034 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.034 |
| March 31, 2026 | 1.067 |
| December 31, 2025 | 1.082 |
| September 30, 2025 | 1.099 |
| June 30, 2025 | 1.173 |
| March 31, 2025 | 1.302 |
| December 31, 2024 | 1.242 |
| September 30, 2024 | 1.146 |
| June 30, 2024 | 1.179 |
| March 31, 2024 | 1.284 |
| December 31, 2023 | 1.35 |
| September 30, 2023 | 1.586 |
| June 30, 2023 | 1.692 |
| March 31, 2023 | 1.769 |
| December 31, 2022 | 1.980 |
| September 30, 2022 | 2.416 |
| June 30, 2022 | 1.350 |
| March 31, 2022 | 1.980 |
| December 31, 2021 | 1.606 |
| September 30, 2021 | 1.660 |
| June 30, 2021 | 1.657 |
| March 31, 2021 | 1.764 |
| December 31, 2020 | 1.861 |
| September 30, 2020 | 1.977 |
| June 30, 2020 | 2.331 |
| Date | Value |
|---|---|
| March 31, 2020 | 2.444 |
| December 31, 2019 | 2.675 |
| September 30, 2019 | 2.807 |
| June 30, 2019 | 9.258 |
| March 31, 2019 | 7.912 |
| December 31, 2018 | 5.978 |
| September 30, 2018 | 6.191 |
| June 30, 2018 | 7.628 |
| March 31, 2018 | -253.00 |
| December 31, 2017 | -251.31 |
| September 30, 2017 | 14.71 |
| June 30, 2017 | 23.27 |
| March 31, 2017 | 10.70 |
| December 31, 2016 | 16.72 |
| September 30, 2016 | 140.30 |
| June 30, 2016 | 34.12 |
| March 31, 2016 | 6.048 |
| December 31, 2015 | 3.252 |
| September 30, 2015 | 3.044 |
| June 30, 2015 | 2.517 |
| March 31, 2015 | 2.483 |
| December 31, 2014 | 4.406 |
| September 30, 2014 | 3.760 |
| June 30, 2014 | 2.885 |
| March 31, 2014 | 2.606 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.7166 |
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.286 |
| Pfizer Inc. | 0.7418 |
| Sanofi | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 81.94B |
| Total Liabilities (Quarterly) | 59.14B |
| Shareholders Equity (Quarterly) | 23.42B |
| Current Ratio | 0.8154 |
| Net Debt Paydown Yield | -0.08% |